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Introduction 
Photon beams conventionally used in radiotherapy 
are shaped by the MultiLeaf Collimator (MLC) and 
the fl attening fi lter (FF). In recent years, there has 
been increasing interest in the removal of fl attening 
fi lter as a factor which gives rise to additional scat-
tering. This kind of beam is called a fl attening fi lter-
-free (FFF) photon beam or an unfl attened beam. 
The removal of the fi lter to obtain FFF beams 
changes the natural peak shape of the beam profi le 
as compared to the conventional FF photon beam. 
Given the development of computational techniques 
in this fi eld, more sophisticated treatment planning 
systems and treatment techniques, the homogeneous 
dose distribution is not required. In view of the fact 
that the dose rate is much higher in FFF beams than 
in FF beams, the use of FFF beams has increased 
substantially. Consequently, the exposure time may 
be shorter and therefore the probability of patient 
movements between fractions may be reduced. 
As stated above, the use of FFF beams is increas-
ingly common in radiotherapy nowadays, meaning 
that their dosimetric parameters should be well 
known to radiotherapy staff. A good understand-
ing of the differences between conventional and 
unfl attened photon beams is needed; nonetheless, 
most of the available publications do not compare 
conventional FF and FFF photon beams, but essen-
tially focus on their usability. Only a few authors of 
the publications on FFF beams made a comparison 
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between these two kinds of photon beams [1, 2]. 
Cashmore described only 6-MV FF and FFF photon 
beams and their dosimetric parameters such as per-
cent depth dose (PDD), beam profi les, total scatter 
correction factor (TSCF), head scatter correction 
factor (HSCF) and wedge factors. All these factors 
were measured at the open and wedge beams using 
semifl ex detectors for a few fi eld sizes and different 
depths. Kragl et al. described the beam profi les, 
PDD, output factors (OFs), leaf transmission and 
leakage and the surface dose for the 6-MV and 
10-MV FF and FFF beams. It should be noted, how-
ever, that neither of these authors took into account 
the clinical applications of FFF beams. 
The other available publications on the subject 
can be divided according to the type of applied 
accelerators: Elekta Co. [3–5] and Varian Co. [5–10]. 
All these authors, except Riis and Fogliata, presented 
dosimetric parameters such as PDD, beam profi les 
and output factors for FFF beams. Riis et al. depicted 
only the OF from Elekta Versa HD. Narayanasamy 
et al. described the wedge factors, MLC character-
ization and mechanical tests for FFF photon beams 
and for electron beams. Paynter et al. exhibited head 
leakage and compared conventional and unfl attened 
beams using both the Elekta Versa HD and Varian 
True Beam accelerators. Fogliata et al. focused on 
the quality assurance of FFF beams in terms of fi eld 
region, fi eld size, penumbra, slope and unfl atness 
for 6-MV and 10-MV FFF beams from Varian True 
Beam. In addition to the main features, some authors 
working on Varian accelerators presented a few dif-
ferent parameters. Mohammed et al. described the 
surface dose and dose rate of 6-MV beams, Pichandi 
et al. introduced the penumbra of 6-MV and 10-MV 
FFF beams. Ting et al. presented the dynamic leaf 
gap for two kinds of beams. Vassiliev et al. described 
the dose rate data and MLC transmission factors of 
6-MV and 18-MV beams without fl attening fi lter. 
Moreover, particular mention should be made of 
a few available conference presentations introducing 
various radiotherapeutic centres interested in FFF 
beams and testing them. The authors presented 
their results at industrial conferences, and their 
achievements are accessible on the Internet, but 
were not published in scientifi c journals [11–13]. 
For instance, Duane et al. presented the basic infor-
mation on the FFF 6-MV photon beams generated 
by the tomotherapy accelerator in the National Physi-
cal Laboratory. They explored the impact of fi lter 
removal on the energy spectrum and ion recombina-
tion and their infl uence on the perturbation effects 
in small fi elds. Kry from the University of Texas 
provided basic information on the parameters of the 
Varian accelerator generating unfl attened beams, 
such as PDDs, profi les, OF, penumbra and MLC leak-
age. In addition, he presented dosimetric parameters 
based on clinical studies and the practical applica-
tions of unfl attened beams (e.g. prostate intensity-
-modulated radiotherapy (IMRT) and stereotactic 
radiotherapy (SRT)). It should be mentioned that 
none of these publications considered all the pos-
sible explorations, characteristics and applications 
of both photon beams. 
The most recent publication on interested photon 
beams is the Institute of Physics and Engineering 
in Medicine – IPEM local report [14], which is in 
essence a guidance for medical physicists on imple-
menting FFF beams in radiotherapy. Budgell et al. 
described the parameters of unfl attened beams such 
as PDDs, beam profi les and output factors generated 
by the Elekta and Varian accelerators and compared 
them with the respective parameters of conventional 
beams. Moreover, the authors expressed their views 
on radiation protection which is analysed using 
parameters such as patient scatter, primary beam, 
leakage, production of neutrons and possibilities 
of the clinical use of FFF beams. In the report, the 
authors also took note of the dosimetric parameters of 
the beams and their verifi cation using various kinds of 
detectors. They provided an example of the clinical use 
of stereotactic radiosurgery (SRS)/body stereotactic 
radiation therapy (SBRT), intensity-modulated radio-
therapy (IMRT)/volumetric modulated arc therapy 
(VMAT) planning and peripheral doses. 
The goal of the present study is to compare 
some basic dosimetric and physical parameters of 
the most commonly used FF and FFF 6-MV and 
10-MV photon beams. This publication presents 
the advantages of FFF on the basis of the measured 
differences between two kinds of photon beams 
taking into account the patient’s comfort during the 
treatment. The dosimetric data contain the following 
characteristics: PDD, beam profi le, edge of a half-
-profi le, head scatter correction factor (HSCF) and 
total scatter correction factor (TSCF). The physical 
parameters include dose distributions, histograms, 
treatment time and, in general, the patient’s health 
and well-being. The measurements were performed 
on the Elekta Versa HD accelerator in the Katowice 
Oncology Center. The applications of FFF beams in 
the clinical treatment are presented. Some advan-
tages of beams without fl attening fi lter such as less 
scattered radiation and easier and more accurate 
modelling of dose distributions in the treatment 
planning system are also discussed. 
Methods 
All the mentioned parameters, such as profi les, 
shape of the edge of half-profi le, PDD, OF, studied by 
several different authors and presented in available 
publications, show the main differences between 
FF and FFF beams. The beam profi le characterizes 
a dose distributed along the axes perpendicular to 
the beam axis. PDD denotes a percentage depth 
dose. It is a ratio of the absorbed dose at a certain 
depth in the medium to the dose at the depth, where 
it reaches its maximum. PDD is visualized as a plot 
in terms of a percentage of the maximum dose. 
Head scatter correction factor (HSCF) describes 
the scattering from the accelerator’s head, while 
total scatter correction factor (TSCF) denotes the 
complete scattering from the accelerator. Another 
feature that can be compared in FF and FFF beams 
is TPR20,10. The tissue phantom ratio (TPR) is the 
ratio of the dose at the isocenter in water at two 
79Clinical advantages of using unfl attened 6-MV and 10-MV photon beams generated by the medical...
different depths, for instance, it is a quotient of the 
dose at the depth of 20 cm to the dose at the depth 
of 10 cm (D20,10) [15–17]. When one uses TPR20,10 
as a quality index (QI), it is measured by described 
D20,10 and expressed by the Followill equation [18]: 
TPR20,10 = 1.2661·D20,10 – 0.0595. 
The physical parameters characterizing the Ele-
kta Versa HD accelerator used in the present study 
are summarized in Table 1. The fi rst three lines 
describe the depth of the maximum dose (dmax), the 
percent dose at the depth of 10 cm (D10) and the 
quality index TPR20,10 for two types of beams, FF 
and FFF, and for two energies, 6 MV and 10 MV. 
The values of dmax, D10 and QI are not signifi cantly 
different for both beams at the same acceleration 
voltage. The lack of fl attening fi lter does not affect 
the quality index which is the same at one voltage 
for both beams. The last two lines indicate that the 
minimum and maximum values of dose rates for 
unfl attened FFF photon beams are much higher 
compared to conventional beams. This feature is 
very desirable in clinical applications. 
Results 
All measurements were carried out in the water 
phantom of the volume of 40 × 40 × 40 cm3 (Blue 
Phantom – IBA) for 6-MV and 10-MV FF and FFF 
beams. Each dosimetric parameter was measured 
in individual way and by specifi c detector. PDDs 
were measured by Markus type PPC05 IBA plane-
-parallel chamber, but others (beam profi les, edge of 
half-profi le and OF) were measured by cylindrical 
CC13 IBA chamber with the active volume equal 
to 0.125 cm3. 
Percent depth dose (PDD) and TPR20,10 
PDD curves were measured starting at the depth 
equal to 275 mm up to the water surface (0 mm). 
The examples of curves are illustrated in Figs. 1a and 
1b. It can be seen that for the same fi eld size, PDD 
curves do not differ from each other in both shape 
and values corresponding to the dose at a given depth. 
Table 2 summarizes a comparison of the charac-
teristic values in the quality index for both types of 
radiation beams generated by the voltage 6 MV and 
10 MV, respectively. The results show a very good 
fi t of FFF beams in the Elekta Versa HD due to the 
sophisticated digital technology used to control 
energy radiation. More importantly, as can be seen 
in Table 2, the application of FFF beams does not 
have any infl uence on the beam quality (TPR20,10), 
so FFF can be commonly used as a conventional 
photon beam. The difference of TPR20,10 for 10-MV 
photons is not relevant to the beam quality, but it 
refl ects different values of D10 and D20. 
Table 1. Parameters of FF and FFF photon beams from the Elekta Versa HD accelerator [19]
Parameter 6-MV FF 6-MV FFF 10-MV FF 10-MV FFF
Maximum dose depth (dmax) [cm] 1.5 1.7 2.1 2.4
Percent dose at the depth of 10 cm (D10) 67.5 67.5 73.0 73.0
Quality index (QI), TPR20,10 0.68 0.68 0.73 0.72
Minimum nominal value of dose rate [MU/min] 30 200 30 400
Maximum nominal value of dose rate [MU/min] 500 1400 500 2200
Table 2. Comparison of measured values of D10 and D20 
for fl attening fi lter (FF) and fl attening fi lter-free (FFF) 
photon beams from Elekta Versa HD in the Katowice 
Oncology Center 
D10 [%] D20 [%] TPR20,10*
6-MV FF    67.81    39.61    0.68
6-MV FFF    67.48    39.24    0.68
Relative difference ±00.33 ±00.37 ±0.00
10-MV FF    72.45    45.49    0.74
10-MV FFF    72.57    44.77    0.72
Relative difference ±00.12 ±00.72 ±0.02
* TPR20,10 = 1.2661·D20,10 – 0.0595 (Followill et al. [18]). 
Fig. 1. Percent depth dose curve of FF and FFF (a) 6-MV and (b) 10-MV photon beams for 10 × 10-cm2 fi eld. 
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Beam profi le characteristics 
Measurements of the percentage dose distributions 
along the axis perpendicular to the central axis of 
the radiation beam were also performed for selected 
fi elds of regular dimension side from 5 × 5 cm2 
to 30 × 30 cm2 and to the depths of 50, 100 and 
200 mm. The examples of curves obtained for a 
10 × 10-cm2 fi eld size are illustrated in Figs. 2b and 
2b. The biggest difference in the shape of the profi le 
can be reported in the high- and low-dose gradient 
(the therapeutic area of the radiation beam), in 
particular for small depths. These differences are 
more pronounced for the 10-MV than 6-MV photon 
beams. As the depth increases, the difference in the 
dose distribution for a certain fi eld size decreases. 
This phenomenon is most likely associated with a 
reduction in the amount of low-energy photons with 
increasing depth in the area of the central axis of 
the FFF photon beam. 
Table 3 summarizes the percentage difference in 
the relative dose for 6-MV and 10-MV FF and FFF 
photon beams measured in the area of the central 
axis outside the beam (high-dose and small-dose 
gradient). All measurements were taken for three 
depths (50, 100 and 200 mm) in the two distances 
from the beam axis (20 and 40 mm). These values 
were selected on account of the clarity of the relative 
differences between used beams. In general, when 
the depth and distance from the beam axis increase, 
the relative dose goes down. The relative difference 
is the dependence between the relative dose of the 
FF beam and FFF beam, with the distance from 
the beam axis, the depth and the accelerating voltage 
remaining the same. For all variables, the relative 
dose is higher for FF beams. This is due to the addi-
tional scattering caused by FF. In addition, one can 
see that for 10-MV beams, the relative differences 
have higher values. This can be explained by the 
fact that the FF absorbs more low-energy photons 
for the high-energy beam. 
Edge of half-profi le
The parameter one should pay close attention 
while analysing these profi les is the change of the 
relative dose value depending on the depth dimen-
sion for 80% of the fi eld size. The relative dose 
value is commonly measured for the fi eld size of 
10 × 10 cm2 and always on source skin distance, 
SSD  100 cm, proportionally for different depths. 
It can be seen in Figs. 3a–3d that for 6-MV and 
10-MV FF photon beams, the relative doses vary 
with the depth, whereas it is not visually observed 
for FFF. This effect is more pronounced for the 
10-MV than 6-MV photon beams. The purpose of 
the presented changes (Figs. 3a–3d) in the profi les 
at the edges of the irradiation fi eld is to check the 
shape disparities of the profi les varying with the depth 
of the FF and FFF 6-MV and 10-MV photon beams. 
The numerical values of the observed effects are 
summarized in Table 4, where the relative doses 
for 80% of the fi eld size for four depths for all the 
studied photon beams are presented. For FF beams, 
the values of the relative doses are bigger than the 
Fig. 2. Differential crossline profi le for the fl attening fi lter (FF) and fl attening fi lter-free (FFF) (a) 6-MV and (b) 
10-MV photon beams, fi eld S = 10 × 10 cm2 for different depth values. 
Table 3. Values of relative doses for FF and FFF photon beams in the area outside the central axis of the beam 
Relative dose [%]
Depth [mm] 50 50 100 100 200 200
Distance from the axis of the beam [mm] 20 40 20 40 20 40
6-MV FF 130.2 125.3 99.80 96.40 57.10 55.20
6-MV FFF 125.2 110.2 96.95 86.82 55.41 50.69
Relative difference 5.0 15.1 2.84 9.58 1.69 4.51
10-MV FF 126.86 119.14 100.29 95.83 61.48 59.48
10-MV FFF 118.87 99.03 94.90 81.17 58.83 51.90
Relative difference 7.99 20.11 6.0 14.66 2.65 7.58
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corresponding ones for FFF beams. This is due to the 
fact that all the profi les are normalized to 100% of 
the relative dose and the profi le curves have different 
shapes. In addition, one can see that for FF beams 
the relative dose decreases as the depth increases, 
in contrast to FFF where the opposite effect is ob-
served, i.e. the dose increases. It is a result of more 
low-energy radiation coming from the FF, while for 
FFF beams the relative dose increases because with-
out the FF, more high-energy photons are present. 
Changes of the relative dose in the therapeutic 
area equal to 80% of the fi eld size are important for 
treatment planning in patients whose tumours are 
located deeply. For this type of location, it is usually 
necessary to enlarge the fi eld size, which in turn 
undesirably increases the dose in healthy tissues 
lying nearby the tumour. Considering the effects 
discussed above, it seems that the use of unfl attened 
FFF beams in radiotherapy planning is justifi ed. 
Output factors (HSCF, TSCF)
The curves showing the comparison of HSCF and 
TSCF output factors for 6-MV and 10-MV FF 
and FFF beams are presented in Figs. 4a, 4b and 
5a, 5b, respectively. An analysis of the shapes of the 
obtained curves may be performed by way of adopt-
ing two distinct approaches. 
The fi rst possibility is to compare the differences 
between each value of the scattering coeffi cients 
for a size of a fi eld greater than 10 × 10 cm2. That 
fi eld is a reference fi eld, and the scatter values are 
normalized to 1. Fields larger than 10 × 10 cm2 were 
taken into account since the scattering is even larger. 
In addition, if one directly compares the values for 
two beams, FF and FFF, with the same acceleration 
voltage, the differences are immediately noticeable. 
Nonetheless, the second more appropriate way of 
analysing the curves of dispersion coeffi cients depends 
on a direct comparison of the differences between 
HSCF and TSCF values for the largest and smallest 
fi eld sizes for two photon beams [20, 21]. This shows 
Fig. 3. Edge of lateral half-profi les for (a) 6-MV FF, (b) 6-MV FFF, (c) 10-MV FF and (d) 10-MV FFF photon beams 
at different depths for the fi eld size of 20 × 20 cm2. Profi les have been standardized to 100% on the central axis. 
Table 4. Values of relative doses for a relative fi eld size equal 
to 80% for FF and FFF photon beams for different depths 
Depth 
[mm]
Relative dose 
[%]
  50 99.32 74.98 100.76 65.31
100 96.68 75.05   98.29 66.25
150 94.09 75.22   96.31 66.99
200 92.37 75.72   94.83 67.87
Fig. 4. Head scatter correction factor curves from the side of the irradiation fi eld for fl attening fi lter (FF) and fl attening 
fi lter-free (FFF) (a) 6-MV and (b) 10-MV photon beams. 
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the spread of scatter values for the extreme sizes 
of the measured fi elds for one type of energy. More-
over, it shows that the dispersion is lower for unfl at-
tened beams for the same value of energy. 
Head scatter correction factor (HSCF) 
HSCF was measured, when the ionization chamber 
was placed at a distance of 100 cm from the radia-
tion source for a range of fi elds from 2 × 2 cm2 to 
40 × 40 cm2. The two approaches outlined above 
may be applied to undertake an analysis of the ob-
tained values shown graphically in Figs. 4a and 4b. 
Under the fi rst approach, as shown in Fig. 4a, 
one can see that the FFF beam has smaller HSCF 
values for all sizes of fi elds and the differences, as 
compared to FF, are less than 0.01. Under the second 
approach, the difference of HSCF data presented in 
Fig. 4a for FF is approximately equal to 0.087, while 
for the beams of unfl attened FFF 0.044. Thus, a de-
crease of 50.6% was observed. On the whole, both 
adopted approaches confi rm that the HSCF values 
for unfl attened FFF photon beams are substantially 
smaller than those for FF beams. 
A similar situation was observed for higher en-
ergy under investigation generated by the voltage of 
10 MV. According to the fi rst criterion, the maximum 
difference between the HSCF value for fi elds larger 
than 10 × 10 cm2 is 0.025. By the second criterion, 
the HSCF value for 10-MV photon beams for the 
largest and smallest fi elds for FF is equal to 0.115, 
while for FFF 0.053. The advantage of FFF of the 
order of 46.1% was also observed. 
Total scatter correction factor (TSCF) 
TSCF measured by ionization chamber was placed 
in a 100-cm distance from the radiation source to 
the conditions, SSD  90 cm, dmeas  10 cm, for a 
range of fi elds from 2 × 2 cm2 to 40 × 40 cm2. The 
same criteria as in HSCF were adopted for the TSCF 
analysis for fl attened and unfl attened beams. The 
measurement results are shown in Figs. 5a and 5b. 
The TSCF curves, as compared to the HSCF 
curves shown in Figs. 4a and 4b, are of a different 
nature. For the fi elds larger than 10 × 10 cm2, the 
TSCF values increase. Moreover, the differences 
in the values of TSCF for FF beams in comparison 
to the values of that coeffi cient for FFF beams also 
increase. The maximum value of the difference is 
0.061 for the fi eld size of 40 × 40 cm2. 
The difference between the extreme values of the 
TSCF is signifi cantly bigger. For FF photon beams, it 
is equal to 0.367, while for FFF 0.281. Although the 
ratio between the values is less than two (1.310), as 
was the case with the HSCF, it can be seen that the 
absolute values of the total scatter correction factor 
for FFF photon beams are smaller. 
Figure 5b shows the curves of TSCF changes for 
the 10-MV photon beams. In comparison to Fig. 4b, 
the ratios of the factors for FF and FFF beams show 
smaller differences from the maximum value of 0.058 
for the fi eld size of 40 × 40 cm2 to the minimum 
value of 0.041 for the fi eld size of 2 × 2 cm2. 
The comparison of the HSCF and TSCF results ob-
tained under the second approach produced the same 
conclusions. The TSCF value between the maximum 
and minimum fi eld sizes was larger for the higher 
energy. For fl attened beams, the difference is equal 
to 0.320, whereas for unfl attened beams it is 0.222. 
Physical parameters 
The overall goal of the treatment plan is to fi t all the 
parameters in such a way as to provide the highest 
probability of the patient’s recovery and minimize 
the treatment time. To this end, treatment plans were 
prepared by one planner for 10 patients for one irradi-
ated region in the treatment planning system (TPS) 
MONACO v.3.30, which uses the Monte Carlo al-
gorithm to calculate the dose. In TPS, we based on 
the same optimization parameters, changed only the 
type of beam for the same irradiated region. TPSs 
compared the dose distributions presented in DVHs 
(called the dose-volume histograms) and the imple-
mentation times for the treatment of selected tumours. 
The comparison was made for the VMAT tech-
nique, which is nowadays a widely used technique of 
conformal treatment. The advantage of VMAT systems 
from ensuring that the therapeutic isodose fi ts pre-
cisely the shape of the tumour, while its disadvantage 
lies the eventuality of irradiation by low doses the 
relatively large volume of normal tissues. The pre-
Fig. 5. Total scatter correction factor curves from the side of the irradiation fi eld for fl attening fi lter (FF) and fl attening 
fi lter-free (FFF) (a) 6-MV and (b) 10-MV photon beams. 
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Fig. 6. Dose distributions for the head/neck area using 6-MV photon beams in the treatment planning system (a) with 
fl attening fi lter (FF) and (b) without fl attening fi lter (FFF) beams. 
Fig. 7. Dose-volume histograms for (a) the head/neck area and (b) pelvis area using 6-MV photon beams in the treat-
ment planning system with fl attening fi lter (FF) and without fl attening fi lter (FFF) beams. 
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pared treatment plans used both kinds of photon 
beams generated with the voltage of 6 MV [22, 23]. 
Figure 6 shows the examples of dose distributions 
for the head/neck area for FF (Fig. 6a) and FFF 
(Fig. 6b) photon beams. Using the FFF rather than 
FF beam, one can see that the tumour is better covered 
by the isodose 95% (5130 cGy – yellow colour) of the 
target dose (5400 cGy), while healthy tissues receive 
lower doses. Moreover, the maximum dose is lower 
for FFF beam than FF beam in the presented plan of 
treatment. The clinical applications of FFF beams and 
the effects of their use throughout the course of treat-
ment were presented on the basis of treatment plans 
from two regions, head/neck and pelvis, using both 
types of photon beams. The results of dose-volume 
histograms are shown in Figs. 7a and 7b, respectively. 
Analysis of the two histograms reveals that the 
organs at risk (OAR) receive much lower doses for 
FFF (dashed lines) than FF (solid lines) beams. This 
means that the probability of side effects of the therapy 
connected with the occurrence of secondary cancer 
tumours is reduced. The curves of the clinical target 
volume (CTV) and planning target volume (PTV) for 
FFF beams covered the corresponding curves for FF 
beams. Thus, the recommendations of ICRU report 
[24] were fulfi lled. These results confi rm that the FFF 
photon beams give a much better dose distribution, 
in particular for OAR. 
Another important parameter affecting the qual-
ity and precision of treatment is the implementation 
time of one fractional dose. The comparison of the 
treatment time for three types of collimators, MLCi2 
for FF beam used in the conventional Elekta Synergy 
accelerators and Agility for both FF and FFF beams 
in the accelerator Elekta Versa HD, is provided in 
Table 5. Table 5 is divided into two parts corre-
sponding to fractional doses lower and higher than 
10 Gy, for four different treatment areas: prostate and 
head/neck and lung and liver, respectively. For each 
region, the number of arcs, total dose and number 
of fractions are listed. In all four cases, the time of 
irradiation is signifi cantly reduced with a simultane-
ous increase in monitor units (MU) by using photon 
beams type FFF generated from the accelerator Ele-
kta Versa HD. Hence, the reduction of treatment time 
increases the patient’s comfort during each session 
and due to patient movements improves the preci-
sion of irradiation dose during treatment. Hence, the 
reduction of treatment time increases the patient’s 
comfort and improves the presicion of irradiation 
dose during each treatment session. 
Discussion 
Five different parameters concerning the quality, 
usability and performance of FF and FFF beams were 
studied. Signifi cant differences between these two 
types of beams were emphasized. The fi rst feature 
discussed was the PDD curve. The results revealed 
and confi rmed the other authors’ conclusion that 
the shape of the PDD curve is not dependent on the 
presence of an FF [1, 8]. The shape of the FFF beam 
profi le would suggest that homogeneity is not main-
tained in the therapeutic area. However, the current 
technology allows one to keep the homogeneity of 
unfl attened beams; moreover, some authors [1, 8] 
claim that the defi nition of individual areas for FFF 
beams should be changed. This is one of the sugges-
tions for the development of research on FFF beams. 
The second parameter under investigation was 
the stability of the beam and hence of the dose at the 
edges of the irradiation fi eld in relation to the depth 
changes. In practice, measurements of the relative 
doses at the edges of the irradiation fi eld were made. 
The results presented in Figs. 3a, 3b and described 
in the literature [2] show that there are apparent 
differences in dose values of 80% of the relative fi eld 
size for FF beams as opposed to FFF beams, where 
the assigned values are almost identical and do not 
alter with the depth (Table 1). 
Scattering coeffi cients (output factors) for the 
FFF beams are signifi cantly smaller than the respec-
tive ones for FF beams, meaning that there is less 
scattered radiation in FFF beams. It can be observed 
in both graphs which show HSCF (Figs. 4a, 4b) 
and also TSCF (Figs. 5a, 5b). For both energies, 
6 MV and 10 MV, it is confi rmed that the values 
of both HSCF and TSCF are defi nitely smaller for 
FFF photon beams than the corresponding values 
Table 5. Comparison of irradiation times for 6-MV FFF beams generated by the Elekta Synergy accelerator and FF 
and FFF beams generated by the Elekta Versa HD accelerator 
Tumour region/number of arcs [MU]
Total dose/number of fractions [s]
Elekta Synergy Elekta Versa HD
MLCi2 (FF) Agility (FF) Agility (FFF)
VMAT technique, fraction dose <10 Gy
Prostate/1 arc 
60 Gy/30 fr. 
789 762 633
171 915 1123
Head and neck/2 arcs 
54 Gy/30 fr. 
635 152 182
293 156 169
VMAT technique, fraction dose >10 Gy
Lung/1 arc
60 Gy/5 fr.
2014 1997 2710
230 2281 2733
Liver/1 arc
60 Gy/5 fr.
2494 245 331
345 130 132
MU – monitor units. 
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of those coeffi cients for conventional beams for the 
same fi eld size. However, the trend of scattering co-
effi cient growth in line with the increasing fi eld size 
does not change after removing the FF. The overall 
decrease in HSCF and TSCF values for unfl attened 
beams is very benefi cial for the patient, since in this 
way the patient is not exposed to an unnecessary 
additional dose. 
All FFF dosimeter parameters are very important, 
because they have a direct impact on the planning 
process of the patient’s therapy. This research pres-
ents tendencies in their behaviour; nonetheless, it 
should be noted that each medical accelerator may 
produce slightly different results. For the accelerator 
Elekta Versa HD, the characteristics of the beams 
and parameters described in the literature to date 
were confi rmed [1, 2, 14]. 
DVHs and the values of the irradiation time 
(Table 5) show the advantages of FFF photon beams 
in radiotherapeutic planning and hence benefi ts for 
patients. Lower doses to OAR with no changes in 
the dose delivered to the tumour area and simultane-
ously shorter irradiation time undermine the future 
of the conventional FF photon beams in favour of 
the unfl attened FFF [25]. 
Conclusions 
In summary, one can draw several conclusions that 
may be relevant to future research: 
 – There are no observed differences of PDD curves 
between conventional FF and unfl attened FFF 
photon beams. The presence of an FF does not 
have any effect on the decrease in the dose in 
relation to depth. 
 – There are insignifi cant differences in the values 
of relative doses depending on the distance from 
the beam axis on the edges of the FFF beam 
profi les for 80% of the relative fi eld size. For the 
FF beams, the differences for the same values 
are signifi cant, which may adversely affect the 
treatment process. 
 – The values of TSCF and HSCF coeffi cients are 
smaller for FFF beams for the studied fi eld sizes. 
Thus, the contribution of scattered radiation in 
the deposited dose is smaller. 
 – The use of FFF photon beams can improve the 
quality of patient treatment by: 
• reducing the irradiation time of fractional doses 
by increasing the dose rate [MU/min], 
• increasing the accuracy of the deposited dose 
through the higher stability of patient’s posi-
tioning due to the shorter irradiation time, 
• reducing the undesired dose at OAR and healthy 
tissues by diminishing the amount of scattered 
radiation. 
The use of radiation FFF beams generated by 
Elekta Versa HD in the Katowice Oncology Center 
increases the applicability of techniques such as: 
VMAT, SRT or SBRT for all locations of cancerous 
tumours. It is highly probable that the benefi ts of 
unfl attened beams will lead to their widespread im-
plementation in the radiotherapeutic planning, most 
probably instead of FF beams. However, there are 
some specifi c issues that still have to be addressed. 
The most important one is the change of the shape 
of the beam profi le, which is directly related to the 
change in the defi nition of the therapeutic area 
and penumbra. Until now, these terms are still not 
standardized for FFF photon beams. 
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